2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

GLYCOPAR – A randomized, placebo-controlled, 2-arm parallel-group superiority phase II study of glycopyrrolate for moderate-to-severe sialorrhea in Parkinson’s disease

T. Mestre, E. Freitas, M. Lopez, A. Basndwah, L. de Oliveira, D. Al-Shorafat, Z. Alarfaz, H. Shinawi, S. Reddie, D. Mancini, J. Lui, D. Grimes, S. Fox (Ottawa, ON, Canada)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Gocovri Dose Adjustment in Elderly Parkinson’s Patients at Risk for Renal Impairment: Implications from an Exposure Simulation Model

I. Isaacson, A. Mittur, R. Patni (Boca Raton, FL, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Grey-matter volume changes underpinning irritability and aggression in early manifest Huntington’s disease

S. Martinez-Horta, F. Sampedro, J. Perez-Perez, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Huntington’s Disease  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Gut Feelings about Parkinson’s Disease: The Influence of the Gut Microbiota in a Rodent Model

A. Gorecki, L. Preskey, M. Bakeberg, J. Kenna, C. Gildenhuys, S. Dunlop, F. Koengten, R. Anderton (Nedlands, Australia)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Gut problems in Huntington’s disease? Evidence for a leaky gut in the R6/2 mouse model of HD

TL. Stan, N. Franke, M. Sjögren, M. Björkqvist (Lund, Sweden)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3

1:45pm-3:15pm

Healthcare Resource Utilization and Costs of Parkinson’s Disease Dementia With Psychosis in the US Medicare Population

J. Wetmore, H. Yan, M. Irfan, Y. Peng, D. Gilbertson, S. Li, N. Rashid, A. Shim (Minneapolis, MN, USA)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Healthcare utilization and emergency department/inpatient costs in adult and pediatric functional neurological disorders

C. Stephen, C. Lungu, A. Espay (Boston, MA, USA)

Functional (Psychogenic) Movement Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Hemi masticatory spasm (HMS) : Series of 7 cases

D. Radhakrishnan, V. Goyal, G. Shukla, M. Singh (New Delhi, India)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Hemiballismus-hemichorea due to ischemic stroke

AM. Magnerou, PE. Sounga Bandzouzi (Douala, Cameroon)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Hemichorea revealing a putaminal cavernous angioma

Y. Mecheri, F. Serradj, BS. Fekraoui, A. Hamri (Constantine, Algeria)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3